Corynebacterium amycolatum: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
a species of aerobic or facultatively anaerobic
{{Taxobox
{{stb}}
| name = Corynebacterium amycolatum
{{dictionary-stub1}}
| regnum = [[Bacteria]]
{{short-articles-ni}}
| phylum = [[Actinobacteria]]
| classis = [[Actinobacteria (class)|Actinobacteria]]
| ordo = [[Corynebacteriales]]
| familia = [[Corynebacteriaceae]]
| genus = [[Corynebacterium]]
| species = ''C. amycolatum''
| binomial = ''Corynebacterium amycolatum''
| binomial_authority = Collins et al. 1988
}}
 
'''''Corynebacterium amycolatum''''' is a species of [[bacteria]] within the genus [[Corynebacterium]], which is part of the family [[Corynebacteriaceae]] of the order [[Corynebacteriales]]. This species is gram-positive, non-spore-forming, and typically exhibits a rod-like shape. ''Corynebacterium amycolatum'' is known for its role in human health, often being isolated from clinical specimens where it can act as an opportunistic pathogen.
 
== Characteristics ==
''Corynebacterium amycolatum'' is characterized by its ability to form irregular, non-pigmented colonies on blood agar. It is catalase-positive and can utilize a variety of carbon sources for energy. This bacterium is predominantly found on the skin and mucous membranes of humans, where it is generally considered to be a part of the normal flora. However, it can cause infections in immunocompromised individuals or when it gains access to normally sterile sites in the body.
 
== Clinical Significance ==
In the clinical setting, ''Corynebacterium amycolatum'' has been associated with a range of infections, including [[bacteremia]], [[endocarditis]], and wound infections. Its identification in clinical microbiology laboratories can be challenging due to its close resemblance to other ''Corynebacterium'' species. Accurate identification is crucial for effective treatment, as this bacterium can exhibit resistance to multiple antibiotics, complicating treatment regimens.
 
== Treatment and Resistance ==
Treatment of infections caused by ''Corynebacterium amycolatum'' typically involves antibiotics, though the bacterium's resistance profile necessitates careful selection of antimicrobial agents. It has shown resistance to traditional antibiotics such as penicillin, making it necessary to rely on more potent drugs like vancomycin or linezolid. The development of antibiotic resistance in ''Corynebacterium amycolatum'' highlights the need for ongoing research and development of new therapeutic strategies.
 
== Research ==
Research on ''Corynebacterium amycolatum'' is focused on understanding its pathogenic mechanisms, resistance patterns, and potential strategies for prevention and treatment of infections. Studies are also directed towards the development of rapid and accurate diagnostic tests that can differentiate ''Corynebacterium amycolatum'' from other similar species.
 
== See Also ==
* [[Corynebacterium]]
* [[Opportunistic infection]]
* [[Antibiotic resistance]]
 
[[Category:Bacteria]]
[[Category:Actinobacteria]]
{{Bacteria-stub}}

Latest revision as of 21:13, 7 August 2024


Corynebacterium amycolatum is a species of bacteria within the genus Corynebacterium, which is part of the family Corynebacteriaceae of the order Corynebacteriales. This species is gram-positive, non-spore-forming, and typically exhibits a rod-like shape. Corynebacterium amycolatum is known for its role in human health, often being isolated from clinical specimens where it can act as an opportunistic pathogen.

Characteristics[edit]

Corynebacterium amycolatum is characterized by its ability to form irregular, non-pigmented colonies on blood agar. It is catalase-positive and can utilize a variety of carbon sources for energy. This bacterium is predominantly found on the skin and mucous membranes of humans, where it is generally considered to be a part of the normal flora. However, it can cause infections in immunocompromised individuals or when it gains access to normally sterile sites in the body.

Clinical Significance[edit]

In the clinical setting, Corynebacterium amycolatum has been associated with a range of infections, including bacteremia, endocarditis, and wound infections. Its identification in clinical microbiology laboratories can be challenging due to its close resemblance to other Corynebacterium species. Accurate identification is crucial for effective treatment, as this bacterium can exhibit resistance to multiple antibiotics, complicating treatment regimens.

Treatment and Resistance[edit]

Treatment of infections caused by Corynebacterium amycolatum typically involves antibiotics, though the bacterium's resistance profile necessitates careful selection of antimicrobial agents. It has shown resistance to traditional antibiotics such as penicillin, making it necessary to rely on more potent drugs like vancomycin or linezolid. The development of antibiotic resistance in Corynebacterium amycolatum highlights the need for ongoing research and development of new therapeutic strategies.

Research[edit]

Research on Corynebacterium amycolatum is focused on understanding its pathogenic mechanisms, resistance patterns, and potential strategies for prevention and treatment of infections. Studies are also directed towards the development of rapid and accurate diagnostic tests that can differentiate Corynebacterium amycolatum from other similar species.

See Also[edit]

Stub icon
   This article is a bacteria-related stub. You can help WikiMD by expanding it!